BioSpace News Archive

Establishment Labs Holdings Inc. (NASDAQ: ESTA), plans to announce its financial results for the quarter ended March 31, 2022 after the market closes on Monday, May 9, 2022, and will host a conference call at 4:30 pm ET that day to discuss those results.

Pfizer Inc. announced that its board of directors declared a $0.40 second-quarter 2022 dividend on the company’s common stock, payable June 10, 2022, to holders of the Common Stock of record at the close of business on May 13, 2022.

Tenaya Therapeutics, Inc. announced that it will present new preclinical data for its TN-401 PKP2 gene therapy program at the Heart Rhythm Society’s upcoming annual Heart Rhythm 2022 meeting.

VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), today announced that tumor response and overall survival data from the ongoing Phase 2a study of VBI-1901, the Company’s cancer vaccine immunotherapeutic candidate in recurrent glioblastoma (GBM), was accepted for presentation at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting.

ExsoMed Corporation, a privately held U.S.-based medical device company providing orthopaedic surgeons with innovative solutions in hand surgery, received 510(k) clearance from the United States Food and Drug Administration (FDA) to commercialize its NanoPhix Cannulated Lag Screw system.

Veru Inc. today announced that it will report financial results for its fiscal 2022 second quarter, on Thursday, May 12, 2022, before the market opens.

Xtant Medical Holdings, Inc. today announced that it will release its financial results for the first quarter ended March 31, 2022, before the open of the financial markets on Thursday, May 5, 2022.

ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company’s first quarter 2022 financial results will be released after market close on Thursday, May 5, 2022.

Allergan, an AbbVie (NYSE: ABBV) company, announced that it will present new data on VUITY at the 2022 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, May 1-4 in Denver, CO.

NEXGEL, Inc today announced that Adam Levy, CEO of NEXGEL, will participate at the Planet MicroCap Showcase 2022 being held in person on May 3-5, 2022.